Numinus Wellness Inc. (OTCMKTS:NUMIF – Get Free Report) saw a significant growth in short interest in the month of January. As of January 15th, there was short interest totaling 796,204 shares, a growth of 39.5% from the December 31st total of 570,851 shares. Based on an average daily volume of 143,881 shares, the short-interest ratio is presently 5.5 days. Based on an average daily volume of 143,881 shares, the short-interest ratio is presently 5.5 days.
Numinus Wellness Price Performance
Numinus Wellness stock opened at C$0.03 on Friday. The firm has a 50 day simple moving average of C$0.04 and a 200-day simple moving average of C$0.04. Numinus Wellness has a 1-year low of C$0.01 and a 1-year high of C$0.06.
Numinus Wellness Company Profile
Numinus Wellness Inc is a Canada-based company focused on the development and delivery of psychedelic-assisted therapies and mental health services. The company operates a network of wellness clinics across several provinces, offering guided psilocybin-assisted therapy sessions under Health Canada’s regulatory framework. Numinus integrates psychological support, medical oversight and integration counselling to address a range of mental health conditions, including depression, anxiety and post-traumatic stress disorder.
Through its Numinus Bioscience division, the company conducts research and development activities in psychedelic compounds such as psilocybin and other novel molecules.
See Also
- Five stocks we like better than Numinus Wellness
- Stock market legend warns: “An Ominous Day Is Coming for the Markets…”
- Another reason you need to own gold… [running out]
- Trump’s Final Shocking Act Begins February 24
- NEW: Gold makes history
- Deutsche Bank Just Raised Their Gold Target to $6,000
Receive News & Ratings for Numinus Wellness Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Numinus Wellness and related companies with MarketBeat.com's FREE daily email newsletter.
